患者近場分子診斷市場規模、佔有率和成長分析：按產品類型、技術、最終用戶、地區和產業預測，2026-2033年

2024年全球患者近距離分子診斷市場價值為11億美元，預計將從2025年的12.1億美元成長到2033年的26.2億美元。預測期（2026-2033年）的複合年成長率預計為10.1%。

全球病患近距離分子診斷市場的發展動力源自於以下幾個面向：對集中式醫療機構以外快速、精準診斷的需求日益成長；感染疾病爆發導致需求增加；以及醫療服務向分散式醫療模式的轉變。小型化的核酸擴增平台正被廣泛應用於這一領域，從而實現即時的臨床決策和有效的公共衛生應對。技術進步和分散化需求正在加速從傳統PCR轉向攜帶式卡盒式系統的過渡。推動這項應用的關鍵因素包括小型化和整合化工作流程，這不僅降低了成本，還提高了檢測的可及性。人工智慧透過自動化訊號分析和內建品質檢查，提高了診斷準確性，從而改善了結果解讀並減少了操作者差異。這些技術的整合有助於在各種醫療環境中，尤其是在社區醫療機構中，以實現及時治療和更有效的監測。

全球患者鄰近分子診斷市場促進因素

全球患者鄰近分子診斷市場正受到醫療服務提供者對就地檢驗)需求日益成長的顯著推動。臨床醫生優先考慮能夠幫助其及時決策並提高工作流程效率的診斷工具。在患者附近進行檢測可最大限度地減少與檢體運輸和後續後續相關的物流挑戰，並增強臨床醫生啟動適當治療的信心。這種接近性有助於將檢測無縫整合到標準臨床實踐中。為此，製造商正在改進其產品設計和支援系統，以適應分散式環境。這擴大了產品的應用範圍，強化了醫療系統的採購流程，並透過持續的臨床應用鞏固了市場需求。

全球患者鄰近分子診斷市場面臨的限制因素

由於各司法管轄區監管要求的複雜性和多樣性，全球患者近場分子診斷市場正面臨嚴峻挑戰。這些要求需要冗長的檢驗流程、詳盡的文件記錄和嚴格的品管措施。製造商必須證明其解決方案即使在分散式環境下也能保持穩定的臨床性能和運作效率，這需要產生大量證據並遵守嚴格的流程控制。這種監管負擔會延長研發週期，增加產品上市的不確定性，最終阻礙小規模創新者的發展，並延緩醫療機構對完全合規且獲得認證的解決方案的採用。因此，這種情況限制了新進入者的湧入，阻礙了市場准入的廣泛普及。

全球患者鄰近分子診斷市場趨勢

全球患者就近分子診斷市場正呈現向分散式醫療整合的顯著趨勢。隨著分子診斷擴大應用於社區醫療和照護現場環境，這種轉變使臨床醫生能夠更快地做出臨床決策，並加強診斷和治療路徑之間的協調。使用者友好且緊湊的平台減少了對中心檢查室的依賴，促進了醫療服務的連續性，並推動了多學科合作。此外，這一趨勢正在改善服務不足地區獲得分子檢測的機會，並需要對醫療服務提供、供應鏈物流和醫護人員培訓等方面的運作模式進行重新設計——所有這些都旨在確保臨床環境中高品質的分子檢測。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

市場考察

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場吸引力指數
• PESTEL 分析
• 監理情勢
• 價值鏈分析

全球患者近場分子診斷市場規模：依產品類型及複合年成長率分類（2026-2033 年）

• 傳染病檢查試劑盒
• 心臟代謝監測套件
• 妊娠及不孕症檢測套組
• 凝血監測試劑盒
• 血液檢測套組
• 尿液檢查試劑盒
• 血糖監測套件
• 其他

全球患者鄰近分子診斷市場規模：依技術及複合年成長率分類（2026-2033 年）

• 基於PCR的技術
• 基因定序技術
• 雜合反應技術
• 基於微陣列的技術

全球患者近場分子診斷市場規模：依最終用戶和複合年成長率分類（2026-2033 年）

• 醫院
• 居家醫療環境
• 診斷檢查室
• 研究所

全球患者鄰近分子診斷市場規模：按地區和複合年成長率分類（2026-2033 年）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 2023-2025年營收年比比較

主要企業簡介

• Roche Diagnostics
• Abbott Laboratories
• Cepheid
• BioMerieux
• QIAGEN
• Illumina
• Siemens Healthineers
• Genomatix
• Ortho Clinical Diagnostics
• HoloEye Photonics
• QuantuMDx
• Aytu BioScience
• Eiken Chemical
• GRAIL
• Bionano Genomics
• LGC Group
• Mia Technologies
• Talis Biomedical
• 10x Genomics
• Caresyntax

結論與建議

Global Near-Patient Molecular Solutions Market size was valued at USD 1.1 Billion in 2024 and is poised to grow from USD 1.21 Billion in 2025 to USD 2.62 Billion by 2033, growing at a CAGR of 10.1% during the forecast period (2026-2033).

The global near-patient molecular solutions market is driven by the growing need for rapid, accurate diagnostics beyond centralized settings, a demand heightened by infectious disease outbreaks and the shift toward decentralized care. This sector features compact nucleic acid amplification platforms that facilitate immediate clinical decision-making and effective public health responses. The evolution from traditional PCR to portable, cartridge-based systems has accelerated, spurred by advances in technology and the decentralization imperative. Key factors enhancing adoption include miniaturization and integrated workflows, which minimize costs and increase testing accessibility. AI is also enhancing diagnostic accuracy through automated signal analysis and embedded quality checks, improving interpretation and reducing operator variability. This convergence of technologies supports timely treatment and better surveillance in diverse healthcare environments, particularly in community settings.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Near-Patient Molecular Solutions market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Near-Patient Molecular Solutions Market Segments Analysis

Global near-patient molecular solutions market is segmented by product type, technology, end user and region. Based on product type, the market is segmented into Infectious Diseases Testing Kits, Cardio Metabolic Monitoring Kits, Pregnancy & Fertility Testing Kits, Coagulation Monitoring Kits, Hematology Testing Kits, Urinalysis Testing Kits, Glucose Monitoring Kits and Others. Based on technology, the market is segmented into PCR-Based Technologies, Genetic Sequencing-Based Technologies, Hybridization Based Technologies and Microarray-Based Technologies. Based on end user, the market is segmented into Hospitals, Homecare Settings, Diagnostic Laboratories and Research Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Near-Patient Molecular Solutions Market

The Global Near-Patient Molecular Solutions market is significantly driven by the increasing preference for point-of-care testing among healthcare providers. Clinicians prioritize diagnostic tools that promote timely decision-making and improve efficiency in workflows. By bringing testing closer to patients, these solutions minimize logistical challenges associated with sample transport and follow-ups, thereby enhancing clinician confidence in starting appropriate treatments. This proximity encourages the seamless integration of testing into standard care practices. In response, manufacturers are evolving their product designs and support offerings for decentralized environments, which expands application possibilities, enhances procurement processes for healthcare systems, and solidifies market demand through ongoing clinical utilization.

Restraints in the Global Near-Patient Molecular Solutions Market

The expansion of the Global Near-Patient Molecular Solutions market faces significant challenges due to complex and varying regulatory requirements that exist across different jurisdictions. These requirements necessitate lengthy validation processes, thorough documentation, and stringent quality control measures. Manufacturers are required to prove their solutions maintain consistent clinical performance and operational effectiveness in decentralized environments, which involves substantial evidence generation and adherence to strict process controls. This regulatory burden can extend development timelines and create uncertainty around product launches, ultimately deterring smaller innovators and slowing adoption among healthcare providers who favor fully compliant and certified solutions. Consequently, this situation limits the influx of new entrants and hinders broader market accessibility.

Market Trends of the Global Near-Patient Molecular Solutions Market

The Global Near-Patient Molecular Solutions market is witnessing a notable trend towards decentralized care integration, where molecular diagnostics are increasingly utilized within community and point-of-care environments. This shift empowers clinicians to make faster clinical decisions, aligning diagnostics more closely with treatment pathways. User-friendly, compact platforms are reducing reliance on centralized labs, fostering continuity of care, and encouraging multidisciplinary collaboration. Additionally, this trend enhances access to molecular testing in underserved areas and necessitates operational redesign in healthcare delivery, supply chain logistics, and practitioner training, all aimed at sustaining high-quality molecular testing at the point of care.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis

Global Near-Patient Molecular Solutions Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Infectious Diseases Testing Kits
• Cardio Metabolic Monitoring Kits
• Pregnancy & Fertility Testing Kits
• Coagulation Monitoring Kits
• Hematology Testing Kits
• Urinalysis Testing Kits
• Glucose Monitoring Kits
• Others

Global Near-Patient Molecular Solutions Market Size by Technology & CAGR (2026-2033)

• Market Overview
• PCR-Based Technologies
• Genetic Sequencing-Based Technologies
• Hybridization Based Technologies
• Microarray-Based Technologies

Global Near-Patient Molecular Solutions Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Homecare Settings
• Diagnostic Laboratories
• Research Laboratories

Global Near-Patient Molecular Solutions Market Size & CAGR (2026-2033)

• North America (Product Type, Technology, End User)
  • US
  • Canada
• Europe (Product Type, Technology, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technology, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genomatix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HoloEye Photonics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuantuMDx
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aytu BioScience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eiken Chemical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GRAIL
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionano Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LGC Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mia Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Talis Biomedical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caresyntax
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations